定量淋巴显像SPECT/CT参数在上肢淋巴水肿评估中的应用
本研究对22例单侧上肢淋巴水肿患者行定量淋巴显像SPECT/CT,测量患肢与健肢的最大淋巴活性(MLA)和总淋巴累积(TLA),并分析其与临床结局的关系。患肢MLA(P=0.0289)和TLA(P<0.001)显著低于健肢;患肢MLA、MLA比值和TLA比值与%RRVI呈显著正相关。作者认为这些参数可能有助于早期发现淋巴功能障碍和预测治疗结局。
要点
- 患肢MLA(P=0.0289)和TLA(P<0.001)显著低于健肢。
- 患肢MLA、MLA比值和TLA比值与%RRVI呈显著正相关。
- 淋巴水肿改善者患肢MLA、MLA比值和TLA比值显著高于持续淋巴水肿者。
核心结论
- 定量淋巴显像SPECT/CT参数在患肢与健肢间存在显著差异,并与治疗反应存在有意义的关联。
- 这些参数可能有助于早期发现淋巴功能障碍和预测治疗结局,并可能有助于改善临床管理。
研究设计与样本
- 本研究纳入22例单侧上肢淋巴水肿患者,行定量淋巴显像SPECT/CT。
- 在患肢和健肢分别测量最大淋巴活性(MLA)和总淋巴累积(TLA)。
- 基线及1个月随访时测量肢体周径,计算相对体积增加(%RVI)和%RVI降低率(%RRVI)。
- 分析患肢与健肢间SPECT/CT衍生参数的差异及其与临床结局的相关性。
主要发现
- 患肢MLA显著低于健肢(P=0.0289)。
- 患肢TLA显著低于健肢(P<0.001)。
- 患肢MLA与%RRVI呈显著正相关(ρ=0.58,P=0.011)。
- 患肢MLA比值与%RRVI呈显著正相关(ρ=0.6,P=0.0077)。
- 患肢TLA比值与%RRVI呈显著正相关(ρ=0.59,P=0.0091)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Lymphedema is a chronic disorder of the lymphatic system. This study evaluated quantitative lymphoscintigraphy SPECT/CT parameters for assessing lymphatic function in patients with unilateral upper extremity lymphedema and examined their relationship with clinical outcomes. PATIENTS AND METHODS: Twenty-two patients with unilateral upper extremity lymphedema underwent quantitative lymphoscintigraphy SPECT/CT. Maximum lymphatic activity (MLA) and total lymphatic accumulation (TLA) were measured in both the affected and the unaffected limbs. Limb circumference measurements were obtained at baseline and 1-month follow-up to calculate the relative volume increase (%RVI) and reduction of %RVI (%RRVI). Differences in SPECT/CT-derived parameters between the affected and the unaffected limbs were analyzed, and their correlations with clinical outcomes were evaluated. RESULTS: MLA ( P =0.0289) and TLA ( P <0.001) were significantly lower in the affected limbs compared with the unaffected limbs. MLA (ρ=0.58, P =0.011), MLA ratio (ρ=0.6, P =0.0077), and TLA ratio (ρ=0.59, P =0.0091) in the affected limbs showed significant positive correlations with %RRVI. Patients with improved lymphedema exhibited significantly higher MLA ( P =0.016), MLA ratio ( P =0.003), and TLA ratio ( P =0.003) in the affected limb compared with those with persistent lymphedema. CONCLUSIONS: Quantitative lymphoscintigraphy SPECT/CT parameters showed significant differences between the affected and the unaffected limbs and demonstrated a meaningful association with treatment response. These parameters may facilitate early detection of lymphatic dysfunction and prediction of therapeutic outcomes, potentially contributing to improved clinical management.
引用
- Na YJ, Lee Y, Kim BS, et al. Quantitative Lymphoscintigraphy SPECT/CT Parameters in the Assessment of Upper Extremity Lymphedema. Clin Nucl Med. 2025. PMID: 40676782. doi:10.1097/RLU.0000000000006043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。